How Does GHK-Cu Work?

The peptide and its copper complex

GHK is the tripeptide glycyl-L-histidyl-L-lysine. A 1988 fibroblast study describes it as a tripeptide with affinity for copper(II) ions that was isolated from human plasma, and refers to the copper-bound form as GHK-Cu. The same paper noted that the sequence GHK occurs as a triplet in the alpha 2(I) chain of type I collagen, and proposed that proteases could release it at a wound site.In vitro · PMID 3169264

A 1982 spectroscopy study defined the complex in solution. At neutral pH, GHK forms a mononuclear 1:1 copper(II) compound with an EPR spectrum resembling copper equatorially coordinated by two or three nitrogen atoms, and electron spin-echo measurements placed one of those nitrogens in the histidyl imidazole ring. The authors noted that the polymeric, oxygen-bridged structure seen earlier in crystals does not exist in solution.In vitro · PMID 6291585

The same study found that the complex changes with pH. Measurements across the pH range showed three optical transitions, with apparent pKs of 3.6, 9.2 and 11.4. Copper binding occurs at the lowest of these, forming the species present at physiological pH, while at higher pH the copper structure alters but the bound imidazole is retained.In vitro · PMID 6291585

How GHK-Cu interacts with cells

Whether the intact complex enters cells is not settled by these studies. A 1989 electron spin resonance study found that GHK-Cu did not form detectable adducts with glutathione or with Ehrlich ascites tumor cells, which the authors read as consistent with poor cellular uptake of the complex. A GHK-Cu-histidine adduct was not stable in the presence of those cells, and the authors argued that a copper-bis-histidine complex forms when GHK interacts with cells.In vitro · PMID 2542448

A 2026 evidence-mapping review made a related point about the wider literature: studies often describe GHK-Cu as a single active ingredient even though coordination state, speciation, stability, pharmacokinetics and toxicity vary with formulation. It separates the free peptide (apo-GHK), canonical GHK-Cu, GHK-derived copper peptides and non-GHK copper-peptide systems, and notes that many delivery studies do not resolve whether intact GHK-Cu or free peptide and free copper is released.Review · PMID 42797253

Collagen and matrix in fibroblasts and rat wounds

The 1988 study measured collagen synthesis by cultured fibroblasts exposed to GHK-Cu. Collagen synthesis rose across a low concentration range and reached its peak at a higher one, and the change occurred without any change in cell number. That last point matters, because it separates a per-cell effect on collagen production from a simple increase in the number of cells.In vitro · PMID 3169264

A 1993 rat study moved the question into living tissue using a wound-chamber model: stainless steel mesh cylinders placed under the skin of the back. Chambers given GHK-Cu showed concentration-dependent increases in dry weight, DNA, total protein, collagen and glycosaminoglycan content compared with saline. Collagen synthesis rose twice as much as noncollagen protein synthesis. Type I and type III collagen mRNAs increased, but TGF beta mRNA did not, and a control tripeptide had no significant effect.Animal study · PMID 8227353

A 2000 follow-up in the same rat model looked at glycosaminoglycans and small proteoglycans. With GHK-Cu, type I collagen and glycosaminoglycan production was higher, chondroitin sulfate and dermatan sulfate accumulated more, decorin mRNA was higher and biglycan mRNA was below control levels in the wound chambers. In rat dermal fibroblast cultures, decorin expression also rose, while biglycan did not change.Animal study · PMID 11121126

Taken together, the three studies describe a consistent pattern in fibroblasts and rat wound tissue: more collagen and glycosaminoglycan, a shift in the balance of the small proteoglycans decorin and biglycan, and no change in TGF beta mRNA. They measured matrix content and gene expression, not the structure or strength of the resulting tissue.In vitro · PMID 3169264Animal study · PMID 8227353Animal study · PMID 11121126

Copper, iron and oxidation

A 1990 study tested whether GHK-Cu acts on iron metabolism. GHK-Cu inhibited lipid peroxidation only when the iron source was ferritin, and it inhibited iron release from ferritin. It did not show significant superoxide dismutase-like or ceruloplasmin-like activity. The authors proposed that the complex binds the ferritin channels involved in iron release and physically blocks the release of iron(II).In vitro · PMID 2244543

That result is a useful check on a common claim. Copper complexes are often assumed to act as general antioxidant enzymes, but in this study the measured effect was specific to ferritin-dependent peroxidation, and enzyme-like superoxide dismutase activity was not significant.In vitro · PMID 2244543

Recent zebrafish and nematode studies

In a 2026 zebrafish larvae study, inflammation was induced with copper sulfate or lipopolysaccharide. With GHK-Cu, migration of neutrophils and macrophages was lower, expression of tnf-a, il-1β and il6 was suppressed, il-10 expression was higher, and nitric oxide and reactive oxygen species levels were lower. The authors reported downregulation of the JAK1 pathway. The study was framed around use of the complex as a cosmetic ingredient.Animal study · PMID 41997403

A 2026 study in the nematode Caenorhabditis elegans reported longer lifespan with GHK-Cu, along with greater resistance to oxidative and thermal stress, higher mitochondrial membrane potential, less mitochondrial network fragmentation, and higher ATP production. It also reported activation of the DAF-16 and SKN-1 pathways and upregulation of sod-3, gst-4, gcs-1, lys-7 and lys-8. These are invertebrate findings and have not been tested in mammals in the studies cited here.Animal study · PMID 42084774

What the GHK-Cu evidence does not settle

The 2026 evidence-mapping review searched sources through 12 August 2026. It concluded that preclinical data consistently support effects on matrix remodeling, epithelial repair, inflammatory and redox regulation and angiogenesis, but that the clinical evidence remains sparse and does not meet contemporary active-entity quality standards. It described historical cosmetic reports as small or incompletely characterized.Review · PMID 42797253

The mechanistic picture is also incomplete. The 1989 spin-resonance work points to poor uptake of the intact complex and copper exchange with histidine at the cell surface. The rat wound-chamber studies measured matrix content and mRNA rather than a receptor or signaling pathway. The review argues that until the chemical state of the complex is defined and controlled clinical studies exist, GHK-Cu should be regarded as promising but unproven.In vitro · PMID 2542448Animal study · PMID 8227353Review · PMID 42797253

The studies at a glance

Key GHK-Cu studies by model. Results are as reported in each paper's abstract.

Frequently asked questions